1 | 4-Hydrazinobenzenesulfonamide Hydrochloride | | 17852-52-7 | Intermediate | Celecoxib(Anti-Inflammatory) |
2 | 4-Methyl acetophenone | | 122-00-9 | Intermediate | Celecoxib(Anti-Inflammatory) |
3 | 4-Bromo-1-chloro-2-(4-ethoxybenzyl)benzene | | 461432-23-5 | Intermediate | Dapagliflozin(Anti-Diabetic) |
4 | (2R,3R,4R,5S,6S)-2-(Acetoxymethyl)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate | | 461432-25-7 | Intermediate | Dapagliflozin(Anti-Diabetic) |
5 | (5-Bromo-2-chlorophenyl)(4-ethoxyphenyl)methanone | | 461432-22-4 | Intermediate | Dapagliflozin(Anti-Diabetic) |
6 | (2S,3R,4S,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol | | 714269-57-5 | Intermediate | Dapagliflozin(Anti-Diabetic) |
7 | (4R,6S)-5,6-Dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-ol 7,7-Dioxide | | 147128-77-6 | Intermediate | Dorzolamide(Glaucoma) |
8 | (5-Bromo-2-chlorophenyl)(4-fluorophenyl)methanone | | 915095-85-1 | Intermediate | Empagliflozin(Anti-Diabetic) |
9 | (3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydrofuran | | 915095-89-5 | Intermediate | Empagliflozin(Anti-Diabetic) |
10 | (S)-(+)-3-Hydroxytetrahydrofuran | | 86087-23-2 | KSM | Empagliflozin(Anti-Diabetic) |
11 | 4-Fluorophenyl-5’-oxobutyric Acid | | 149437-76-3 | Intermediate | Ezetimibe(Anti-Hyperlipidemic) |
12 | (4S)-4-Phenyl-3-[5-(4-fluorophenyl)-5-oxopentanoyl]-1,3-oxazolidin-2-one; | | 189028-93-1 | Intermediate | Ezetimibe(Anti-Hyperlipidemic) |
13 | 4-[[(4-Fluorophenyl)imino]methyl]phenol | | 3382-63-6 | Intermediate | Ezetimibe(Anti-Hyperlipidemic) |
14 | (R)-N-(4-Nitrophenethyl)-2-hydroxy-2-phenylacetamide | | 521284-19-5 | Intermediate | Mirabegron(Urology) |
15 | (R)-2-((4-Nitrophenethyl)amino)-1-phenylethanol Hydrochloride | | 521284-21-9 | Intermediate | Mirabegron(Urology) |
16 | (R)-2-((4-Aminophenethyl)amino)-1-phenylethanol | | 391901-45-4 | Intermediate | Mirabegron(Urology) |
17 | (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-5-carboxylate | | 144690-92-6 | Intermediate | Olmesartan(Hypertension) |
18 | 4-(4-Aminophenyl)-3-morpholinone | | 438056-69-0 | Intermediate | Rivaroxaban(Cardiovascular) |
19 | 5-Chlorothiophene-2-carboxylic acid | | 24065-33-6 | Intermediate | Rivaroxaban(Cardiovascular) |
20 | (S)-2-(Oxiran-2-ylmethyl)-1H-isoindole-1,3(2H)-dione | | 161596-47-0 | Intermediate | Rivaroxaban(Cardiovascular) |
21 | (R)-2-(2-Hydroxy-3-((4-(3-oxomorpholino)phenyl)amino) propyl)isoindoline-1,3-dione | | 46292-07-5 | Intermediate | Rivaroxaban(Cardiovascular) |
22 | (S)-2-((2-Oxo-3-(4-(3-oxomorpholino)phenyl) oxazolidin-5-yl)methyl)isoindoline-1,3-dione | | 446292-08-6 | Intermediate | Rivaroxaban(Cardiovascular) |
23 | (S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one hydrochloride | | 898543-06-1 | Intermediate | Rivaroxaban(Cardiovascular) |
24 | 4-Nitrophenyl 5-chlorothiophene-2-carboxylate | | 1450877-56-1 | Intermediate | Rivaroxaban(Cardiovascular) |
25 | 1,1-Bis(hydroxymethyl)cyclopropane | | 39590-81-3 | KSM | Montelukast(Respiratory) |
26 | 8-Bromo-3-methyl-7-(2-butynyl)-xanthine | | 666816-98-4 | Intermediate | Linagliptin(Anti-Diabetic) |
27 | 2-(Chloromethyl)-4-methylquinazoline | | 109113-72-6 | Intermediate | Linagliptin(Anti-Diabetic) |
28 | 8-Bromo-3-methylxanthine | | 93703-24-3 | Intermediate | Linagliptin(Anti-Diabetic) |
29 | 8-Bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione | | 853029-57-9 | Intermediate | Linagliptin(Anti-Diabetic) |
30 | 3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride | | 762240-92-6 | Intermediate | Sitagliptin(Anti-Diabetic) |
31 | 1-(3-(Trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butane-1,3-dione | | 764667-65-4 | Intermediate | Sitagliptin(Anti-Diabetic) |
32 | (2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)but-2-en-2-amine | | 767340-03-4 | Intermediate | Sitagliptin(Anti-Diabetic) |
33 | 7-[1-Oxo-3-amino-4-(2,4,5-trifluorophenyl)butyl]-3-(trifluoromethyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyrazine | | 823817-56-7 | Intermediate | Sitagliptin(Anti-Diabetic) |
34 | Methyl 3-Oxo-4-(2,4,5-trifluorophenyl)butanoate | | 769195-26-8 | Intermediate | Sitagliptin(Anti-Diabetic) |
35 | (Z)-Methyl 3-amino-4-(2,4,5-trifluorophenyl)but-2-enoate | | 881995-70-6 | Intermediate | Sitagliptin(Anti-Diabetic) |
36 | (Z)-Methyl 3-acetamido-4-(2,4,5-trifluorophenyl)but-2-enoate | | 1234321-81-3 | Intermediate | Sitagliptin(Anti-Diabetic) |
37 | Methyl (R)-3-acetamido-4-(2,4,5-trifluorophenyl)butanoate | | 1234321-83-5 | Intermediate | Sitagliptin(Anti-Diabetic) |
38 | 2,2-Dimethyl-1,3-dioxane-4,6-dione (Meldrum's acid) | | 2033-24-1 | KSM | Sitagliptin(Anti-Diabetic) |
39 | (-)-Corey Lactone Diol | | 32233-40-2 | Intermediate | iloprost(prostaglandin I2) |
40 | (S)-2-Amino-3-((S)-2-oxopyrrolidin-3-yl)propanamide Hydrochloride | | 2628280-48-6 | KSM | Nirmatrelvir(Anti-Viral) |
41 | 5-Bromo-2-chloropyrimidine | | 32779-36-5 | KSM | Macitentan(Anti-hypertensive) |
42 | (S)-1-(4-Phenyl-1H-imidazol-2-yl)ethanamine | | 864825-23-0 | KSM | Eluxadoline(Diarrhea) |
43 | 4-Nitrophenethylamine Hydrochloride | | 29968-78-3 | KSM | Mirabegron(Urology) |
44 | N-Methyl-2-(4-nitrophenyl)ethanamine Hydrochloride | | 166943-39-1 | KSM | Dofetilide(Anti-arrhythmic) |
45 | 1-(2-Chloroethoxy)-4-nitrobenzene | | 3383-72-0 | KSM | Dofetilide(Anti-arrhythmic) |
46 | 3-Quinuclidinone Hydrochloride | | 1193-65-3 | API KSM | Solifenacin succinate (Urology) |
47 | 2-Hydroxy-5-methylpyridine/5-methylpyridin-2-ol | | 1003-68-5 | KSM | Pirfenidone (Anti-fibrotic/inflammatory/antioxidant) |
48 | N-(Tosylmethyl)formamide | | 36635-56-0 | Intermediates | BEMPEDOIC ACID(Cardiovascular) |
49 | Tosylmethyl isocyanide (1-(isocyanatomethylsulfonyl)-4-methylbenzene.) | | 10564-55-3 | Intermediates | BEMPEDOIC ACID(Cardiovascular) |
50 | 2,2,14, 14-Tetramthyl-8-oxopentadecanedioic acid | | 13624-71-2 | Intermediates | BEMPEDOIC ACID(Cardiovascular) |
51 | 2,6-Dichloro-3,5-dimethoxyaniline | | 872509-56-3 | Intermediates | Infigratinib(Oncology) |
52 | 6-Chloro-N-methylpyrimidin-4-amine | | 65766-32-7 | Intermediates | Infigratinib(Oncology) |
53 | 5-bromo uracil | | 51-20-7 | Intermediates | Palbociclib (Oncology) |
54 | 5-Bromo-2,4-dichloropyrimidine | | 36082-50-5 | Intermediates | Palbociclib (Oncology) |
55 | 5-bromo-2-chloro-N-cyclopentylpyrimidin-4-amine | | 733039-20-8 | Intermediates | Palbociclib (Oncology) |
56 | 2-chloro-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one | | 1013916-37-4 | Intermediates | Palbociclib (Oncology) |
57 | 6-bromo-2-chloro-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one | | 1016636-76-2 | Intermediates | Palbociclib (Oncology) |
58 | tert-butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate | | 571188-59-5 | Intermediates | Palbociclib (Oncology) |
59 | tert-butyl 4-(6-((6-bromo-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate | | 571188-82-4 | Intermediates | Palbociclib (Oncology) |
60 | 4-chloro-7H-pyrrolo[2 ,3-d]pyrimidine | | 3680-69-1 | Intermediates | Tofacitinib (Rheumatoid arthritis) |
61 | 4-chloro-7-tosyl-7-H-pyrrolo[2,3-d]pyrimidine | | 479633-63-1 | Intermediates | Tofacitinib (Rheumatoid arthritis) |
62 | (3R,4R)-N,4-Dimethyl-1-(phenylmethyl)-3-piperidinamine hydrochloride | | 1062580-52-2 | Intermediates | Tofacitinib (Rheumatoid arthritis) |
63 | 1-methyl-1H-indole | | 603-76-9 | Intermediates | Osimertinib (Oncology) |
64 | 3-(2-chloropyrimidin-4-yl)-1-methyl-1H-indole | | 1032452-86-0 | Intermediates | Osimertinib (Oncology) |
65 | 4-fluoro-2-methoxy-5-nitroaniline | | 1075705-01-9 | Intermediates | Osimertinib (Oncology) |
66 | (4-Fluoro-2-methoxy-5-nitro-phenyl)-[4-(1-methyl-1H-indol-3-yl)-pyrimidin-2-yl]-amine | | 1421372-94-2 | Intermediates | Osimertinib (Oncology) |
67 | 4,6-dichloro-5-nitro-2-(propylthio)pyrimidine | | 145783-14-8 | Intermediates | Ticagrelor (Cardiovascular) |
68 | 4,6-dichloro-2-(propylthio)pyrimidin-5-amine | | 145783-15-9 | Intermediates | Ticagrelor (Cardiovascular) |
69 | (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine (2R)-Hydroxy(phenyl)ethanoate | | 376608-71-8 | Intermediates | Ticagrelor (Cardiovascular) |
70 | 2,4-dichloropyrimidine | | 3934-20-1 | Intermediates | Pazopanib (Oncology) |
71 | 3-methyl-6-nitro-2H-indazole | | 6494-19-5 | Intermediates | Pazopanib (Oncology) |
72 | 2,3-dimethyl-6-nitro-2H-indazole | | 444731-73-1 | Intermediates | Pazopanib (Oncology) |
73 | 2,3-dimethyl-2H-indazol-6-amine hydrochloride | | 635702-60-2 | Intermediates | Pazopanib (Oncology) |
74 | N-(2-chloropyrimidin-4-yl)-2,3-dimethyl-2H-indazol-6-amine | | 444731-74-2 | Intermediates | Pazopanib (Oncology) |
75 | 5-amino-2-methylbenzenesulfonamide | | 6973-09-7 | Intermediates | Pazopanib (Oncology) |
76 | 2-Fluoro-4-nitrotoluene | | 1427-07-2 | Intermediates | Enzalutamide (Oncology) |
77 | 2-fluoro-4-nitrobenzoic acid | | 403-24-7 | Intermediates | Enzalutamide (Oncology) |
78 | Ethyl 4-amino-2-fluorobenzoate | | 73792-06-0 | Intermediates | Enzalutamide (Oncology) |
79 | 4-amino-2-fluoro-N-methylbenzamide | | 915087-25-1 | Intermediates | Enzalutamide (Oncology) |
80 | Bromo Isobutyric acid | | 2 0 5 2-01-9 | Intermediates | Enzalutamide (Oncology) |
81 | 5-nitroindoline-2,3-dione | | 611-09-6 | Intermediates | Tucatanib(Oncology) |
82 | 2-amino-5-nitrobenzonitrile | | 17420-30-3 | Intermediates | Tucatanib(Oncology) |
83 | (E)-N'-(2-cyano-4-nitrophenyl)-N,N-dimethylformimidamide | | 39263-34-8 | Intermediates | Tucatanib(Oncology) |
84 | 5-Amino-2,4-di-tert-butyl-phenol | | 873055-58-4 | Intermediates | Ivacaftor(cystic fibrosis) |
85 | 4-Oxo-1,4-dihydro-quinoline-3-carboxylic acid | | 13721-01-2 | Intermediates | Ivacaftor(cystic fibrosis) |
86 | thiazolidine-2,4-dione | | 2295-31-0 | Intermediates | Piogliazone(Anti-Diabetic) |
87 | 4-(2-(5-ethylpyridin-2-yl)ethoxy)benzaldehyde | | 114393-97-4 | Intermediates | Piogliazone(Anti-Diabetic) |
88 | 5-(4-(2-(5-ethylpyridin-2-yl)ethoxy)benzyl)thiazolidine-2,4-dione | | 111025-46-8 | Intermediates | Piogliazone(Anti-Diabetic) |
89 | 4,6-dihydroxypyrimidine | | 1193-24-4 | KSM | Common Intermediates |
90 | 5-bromopyridin-2-amine | | 1072-97-5 | KSM | Common Intermediates |
91 | 5-bromo-3-nitropyridin-2-amine | | 6945-68-2 | KSM | Common Intermediates |
92 | 5-bromopyridine-2,3-diamine | | 38875-53-5 | KSM | Common Intermediates |
93 | 2-Isopropoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | | 61676-62-8 | KSM | Common Intermediates |
94 | 3-chloro-2-methylbenzenethiol | | 53249-76-6 | KSM | Common Intermediates |
95 | N-Boc-1,4-butanediamine | | 68076-36-8 | KSM | Common Intermediates |
96 | bromo acetaldehyde diethyl acetal | | 2032-35-1 | KSM | Common Intermediates |
97 | phenyl(piperazin-1-yl)methanone | | 13754-38-6 | KSM | Common Intermediates |
98 | 3-methyl-1H-1,2,4-triazole | | 06-01-70 | KSM | Common Intermediates |
99 | (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile | | 207557-35-5 | Intermediates | Vildagliptin(anti-hyperglycemic) |
100 | (2S)-1-[2-[(3-hydroxy-1-adamantyl)amino]acetyl] pyrrolidine-2-carbonitrile | | 274901-16-5 | Intermediates | Vildagliptin(anti-hyperglycemic) |
101 | 2-isopropoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | | 61676-62-8 | Intermediates | Ruxolitinib (Oncology) |
102 | 4-Bromopyrazole | | 2075-45-8 | Intermediates | Ruxolitinib (Oncology) |
103 | 4-Bromo-1-(1-ethoxyethyl)-1H-pyrazole | | 1024120-52-2 | Intermediates | Ruxolitinib (Oncology) |
104 | 1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | | 1029716-44-6 | Intermediates | Ruxolitinib (Oncology) |
105 | 4-Pyrazoleboronic acid pinacol ester | | 269410-08-4 | Intermediates | Ruxolitinib (Oncology) |
106 | 5-Cyanophthalide | | 82104-74-3 | KSM | Citalopram |
107 | 1-(2-Ethoxyethyl)-2-(piperidin-4-yl)-1H-benzo[d]imidazole hydrochloride | | 1841081-72-8 | Intermediate | Bilastine (antiallergic) |
108 | 2-(4-(2-Chloroethyl)phenyl)-N-methoxy-N,2-dimethylpropanamide | | 1638785-17-7 | Intermediate | Bilastine (antiallergic) |
109 | 4-Bromo-1H-imidazole | | 2302-25-2 | KSM | Common Intermediate |
110 | 4,5-Dichlorobenzene-1,2-diamine | | 5348-42-5 | Intermediate | Maribavir(Anti-Viral) |
111 | 2-Nitro-4-(propylthio)aniline | | 54393-89-4 | Intermediate | Albendazole (antihelmintics) |
112 | 4-(Propylthio)benzene-1,2-diamine | | 66608-52-4 | Intermediate | Albendazole (antihelmintics) |
113 | 4,4-bis(3-methylthiophen-2-yl)but-3-en-1-ol | | 847233-27-6 | Intermediate | Tigabine (anticonvulsant) |
114 | 4,4-Bis(3-methylthiophen-2-yl)but-3-enyl methanesulfonate | | 847233-13-0 | Intermediate | Tigabine (anticonvulsant) |
115 | Ethyl (R)-1-(4,4-bis(3-methylthiophen-2-yl)but-3-en-1-yl)piperidine-3-carboxylate | | | | Tigabine (anticonvulsant) |
116 | 3-Chloro-4-methoxybenzylamine Hydrochloride | | 41965-95-1 | KSM | Avanafil (PDE5 inhibitor) |
117 | 6-Nitroquinoxaline | | 6639-87-8 | Intermediate | Brimonidine (alpha adrenergic agonists) |
118 | 6-Aminoquinoxaline | | 6298-37-9 | Intermediate | Brimonidine (alpha adrenergic agonists) |
119 | 6-Amino-5-bromoquinoxaline | | 50358-63-9 | Intermediate | Brimonidine (alpha adrenergic agonists) |
120 | 5-Bromo-6-isothiocyanatoquinoxaline | | 134892-46-9 | Intermediate | Brimonidine (alpha adrenergic agonists) |
121 | | Diethyl 2-methyl-2-(3-oxocyclohexyl)malonate | 52263-19-1 | Intermediate | Carprofen (anti-inflammatory) |
122 | Diethyl 2-(6-chloro-2,3,4,9-tetrahydro-1H-carbazol-2-yl)-2-methylmalonate | | 71208-54-3 | Intermediate | Carprofen (anti-inflammatory) |
123 | Diethyl 2-(6-chloro-9H-carbazol-2-yl)-2-methylmalonate | | 71208-55-4 | Intermediate | Carprofen (anti-inflammatory) |
124 | Dimethyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | | 21881-77-6 | Intermediate | Nicardipine (calcium channel blockers) |
125 | 5-(methoxycarbonyl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylic acid | | 74936-71-3 | Intermediate | Nicardipine (calcium channel blockers) |
126 | 1-Phthalazinone | | 20055-18-9 | Common Intermediate | |
127 | 5-Methyl-N-(4-(trifluoromethyl)phenyl)isoxazole-4-carboxamide | | 75706-12-6 | Intermediate | Leflunomide/Teriflunomide (Relapsing MS) |
128 | 1-(6-Methylpyridin-3-yl)-2-(4-(methylsulfonyl)phenyl)ethanone | | 221615-75-4 | Intermediate | Etoricoxib (Anti-inflammatory) |
129 | 4-Amino Benzonitrile | | 873-74-5 | KSM | Dabigatran (Anti Coagulant) |
130 | (E)-4-amino-N'-hydroxybenzimidamide | | 277319-62-7 | Intermediate | Dabigatran (Anti Coagulant) |
131 | 4-Aminobenzamidine Dihydrochloride | | 2498-50-2 | Intermediate | Dabigatran (Anti Coagulant) |
132 | 4-Chloro 3-Nitro Benzoic acid | | 96-99-1 | KSM | Dabigatran (Anti Coagulant) |
133 | 4-(methylamino)-3-nitrobenzoic acid | | 41263-74-5 | KSM | Dabigatran (Anti Coagulant) |
134 | 2-(4-Cyano phenyl amino) acetic acid | | 42288-26-6 | Intermediate | Dabigatran (Anti Coagulant) |
135 | Ethyl 3-(Pyridin-2yl amino) Propionate | | 103041-38-9 | Intermediate | Dabigatran (Anti Coagulant) |
136 | Ethyl 3-(4-(methylamino)-3-nitro-N-(pyridin-2-yl)benzamido)propanoate | | 429659-01-8 | Intermediate | Dabigatran (Anti Coagulant) |
137 | Ethyl 3-(3-amino-4-(methylamino)-N-(pyridin-2-yl)benzamido)propanoate | | 212322-56-0 | Intermediate | Dabigatran (Anti Coagulant) |
138 | Ethyl 3-(2-(((4-cyanophenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate | | 211915-84-3 | Intermediate | Dabigatran (Anti Coagulant) |
139 | 4-(3,4-Dichlorophenyl)-3,4-dihydronaphthalen-1(2H)-one, | | 79560-19-3 | Intermediate | Sertraline HCl (Depression and OCD) |
140 | 4-(3,4-dichlorophenyl)-N-methyl-3,4-dihydro-2H-naphthalen-1-imine | | 79560-20-6 | Intermediate | Sertraline HCl (Depression and OCD) |
141 | L-Prolinamide | | 7531-52-4 | KSM | Vildagliptin (Anti-hyperglycemic) |
142 | 3-Aminoadamantan-1-ol | | 702-82-9 | KSM | Vildagliptin (Anti-hyperglycemic) |
143 | 1-(3-Chloropropyl)-1H-benzo[d]imidazol-2(3H)-one | | 62780-89-6 | Intermediate | Domperidone (Anti-Sickness) |
144 | N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine | | 152460-10-1 | Intermediate | Imatinib Mesylate (Oncology) |
145 | 4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride | | 106261-49-8 | Intermediate | Imatinib Mesylate (Oncology) |
146 | Ethyl piperidine-4-carboxylate | | 1126-09-6 | KSM | Solifenacin (Overactive Bladder) |
147 | Piperidine-4-carboxylic acid | | 498-94-2 | Common Intermediate | Solifenacin/ Azacyclonol/ Bilastine/ Cevimeline /Palonosetron |
148 | 1-(tert-Butoxycarbonyl)piperidine-4-carboxylic acid | | 84358-13-4 | Common Intermediate | Solifenacin/ Azacyclonol/ Bilastine/ Cevimeline /Palonosetron |
149 | tert-Butyl piperazine-1-carboxylate | | 57260-71-6 | Common Intermediate | Solifenacin/ Azacyclonol/ Bilastine/ Cevimeline /Palonosetron |
150 | Ethyl 1-(2-ethoxy-2-oxoethyl)piperidine-4-carboxylate | | 1838-39-7 | KSM | Solifenacin Succinate (Overactive Bladder) |
151 | 3-Quinuclidinone HCl | | 1193-65-3 | KSM | Solifenacin Succinate (Overactive Bladder) |
152 | 3-(+/-)-Quinuclidinol | | 1619-34-7 | KSM | Solifenacin Succinate (Overactive Bladder) |
153 | (R)-3-Quinuclidinol | | 25333-42-0 | KSM | Solifenacin Succinate (Overactive Bladder) |
154 | N-(2-Phenyl ethyl)benzamide | | 3278-14-6 | KSM | Solifenacin Succinate (Overactive Bladder) |
155 | 1-Phenyl-1,2-dihydro Isoquinoline | | 134021-15-1 | KSM | Solifenacin Succinate (Overactive Bladder) |
156 | 1-Phenyl-1,2,3,4-tetrahydroisoquinoline | | 22990-19-8 | KSM | Solifenacin Succinate (Overactive Bladder) |
157 | (S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline | | 118864-75-8 | KSM | Solifenacin Succinate (Overactive Bladder) |
158 | Tert-butyl-3-hydroxypiperidine-1-carboxylate | | 85275-45-2 | Common Intermediate | Linagliptin/ Alogliptin/ Trelagliptin |
159 | 1-Boc-3-piperidone | | 98977-36-7 | Common Intermediate | Linagliptin/ Alogliptin/ Trelagliptin |
160 | 1-Boc-3-aminopiperidine | | 184637-48-7 | Common Intermediate | Linagliptin/ Alogliptin/ Trelagliptin |
161 | (R)-tert-butyl piperidin-3-ylcarbamate | | 309956-78-3 | Common Intermediate | Linagliptin/ Alogliptin/ Trelagliptin |
162 | (R)-tert-butyl-3-aminopiperidine-1-carboxylate | | 188111-79-7 | Common Intermediate | Linagliptin/ Alogliptin/ Trelagliptin |
163 | (R)-Piperidin-3-amine dihydrochloride | | 334618-23-4 | Common Intermediate | Linagliptin/ Alogliptin/ Trelagliptin |
164 | Cyclopropane-1,1-dicarboxylic acid | | 598-10-7 | KSM | Cabozantinib (Oncology) |
165 | 3-(chloromethyl)-5-methylpyridine hydrochloride | | 1007089-84-0 | KSM | Rupatadine Fumarate (allergic rhinitis) |
166 | N-Methyl-1-(naphthalen-1-yl)methanamine hydrochloride, | | 65473-13-4 | KSM | Terbinafine HCl (fungal infections) |
167 | N-[4-(2-Chloroacetyl)Phenyl]Methanesulfonamide | | 64488-52-4 | KSM | Sotalol HCl (arrhythmia) |
168 | 3-Aminopiperidine-2,6-dione hydrochloride | | 24666-56-6 | KSM | Linalidomide (Oncology) |
169 | Methyl 2-(bromomethyl)-3-nitrobenzoate | | 98475-07-1 | KSM | Linalidomide (Oncology) |
170 | 3-[2-(3-Chlorophenyl)ethyl]-2-pyridine carbonitrile | | 31255-57-9 | Common Intermediate | Loratidine / Deslaratidine / Rupatidine |
171 | 3-(3-Chlorophenethyl)pyridine | | 31251-59-9 | Common Intermediate | Loratidine / Deslaratidine / Rupatidine |
172 | 2-Amino-5-methylthiophene-3-carbonitrile | | 138564-58-6 | Intermediate | Olanzapine (schizophrenia) |
173 | 5-Methyl-2-[(2-nitrophenyl)amino]thiophene-3-carbonitrile | | 138564-59-7 | Intermediate | Olanzapine (schizophrenia) |
174 | 2-Methyl-10H-benzo[b]thieno[2,3-e][1,4]diazepin-4-amine hydrochloride | | 138564-60-0 | Intermediate | Olanzapine (schizophrenia) |
175 | Ethyl 2,3-dibromopropionate | | 3674-13-3 | KSM | Doxazocin (hypertension) |
176 | Methyl 2,3-dibromopropionate | | 1729-67-5 | KSM | Doxazocin (hypertension) |
177 | 10,11-Dihydro-11-oxodibenzo[b,f][1,4]thiazepine | | 07-07-59 | Intermediate | Quetiapine Fumarate (schizophrenia) |
178 | 6-Fluorochroman-2-carboxylic acid | | 99199-60-7 | Intermediate | Nebivolol (hypertension) |
179 | 5-(2-Fluorophenyl)-1H-pyrrole-3-carbaldehyde | | 881674-56-2 | Intermediate | Vonoprazan |